Preventing myocardial infarction with vaccination: Myths and realities

JAMA

Volumn 303, Issue 17, 2010, Pages 1751-1752

  Madjid, Mohammad ^a   Musher, Daniel M ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; CLOPIDOGREL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLACEBO; PNEUMOCOCCUS VACCINE;

ATHEROGENESIS; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; DRUG EFFICACY; EDITORIAL; HEART INFARCTION; HUMAN; INFECTION RISK; PNEUMOCOCCAL INFECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPHYLAXIS; AGED; MALE; MIDDLE AGED; NOTE; REPRODUCIBILITY; RETROSPECTIVE STUDY; STREPTOCOCCUS PNEUMONIA;

AGED; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PNEUMOCOCCAL VACCINES; PNEUMONIA, PNEUMOCOCCAL; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES;

EID: 77951881807     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2010.571     Document Type: Editorial

References (14)

1. Madjid M, Miller CC, Zarubaev VV, et al. Influenza epidemics and acute respiratory disease activity are associated with a surge in autopsy-confirmed coronary heart disease death: results from 8 years of autopsies in 34892 subjects. Eur Heart J. 2007;28(10):1205-1210. (Pubitemid 47343835)
2. Warren-Gash C, Smeeth L, Hayward AC. Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. Lancet Infect Dis. 2009;9(10):601-610.
3. Corrales-Medina VF, Madjid M, Musher DM. Role of acute infection in triggering acute coronary syndromes. Lancet Infect Dis. 2010;10(2):83-92.
4. Madjid M, Aboshady I, Awan I, Litovsky S, Casscells SW. Influenza and cardiovascular disease: is there a causal relationship? Tex Heart Inst J. 2004;31 (1):4-13. (Pubitemid 38366809)
5. Tseng HF, Slezak JM, Quinn VP, Sy LS, Van Den Eeden SK, Jacobsen SJ. Pneumococcal vaccination and risk of acute myocardial infarction and stroke in men. JAMA. 2010;303(17):1699-1706.
6. Jackson LA, Jackson ML, Nelson JC, Neuzil KM, Weiss NS. Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol. 2006; 35(2):337-344.
7. Huss A, Scott P, Stuck AE, Trotter C, Egger M. Efficacy of pneumococcal vaccination in adults: a meta-analysis. CMAJ. 2009;180(1):48-58.
8. Jackson LA, Neuzil KM, Yu O, et al; Vaccine Safety Datalink. Effectiveness of pneumococcal polysaccharide vaccine in older adults. N Engl J Med. 2003; 348(18):1747-1755.
9. Moberley SA, Holden J, Tatham DP, Andrews RM. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev. 2008;(1):CD000422. (Pubitemid 351807720)
10. Johnstone J, Marrie TJ, Eurich DT, Majumdar SR. Effect of pneumococcal vaccination in hospitalized adults with community-acquired pneumonia. Arch Intern Med. 2007;167(18):1938-1943. (Pubitemid 47606632)
11. Lamontagne F, Garant MP, Carvalho JC, Lanthier L, Smieja M, Pilon D. Pneumococcal vaccination and risk of myocardial infarction. CMAJ. 2008;179(8): 773-777.
12. Casscells SW, Granger E, Kress AM, Linton A, Madjid M, Cottrell L. Use of oseltamivir after influenza infection is associated with reduced incidence of recurrent adverse cardiovascular outcomes among military health system beneficiaries with prior cardiovascular diseases. Circ Cardiovasc Qual Outcomes. 2009; 2(2):108-115.
13. Madjid M, Curkendall S, Blumentals WA. The influence of oseltamivir treatment on the risk of stroke after influenza infection. Cardiology. 2009;113(2): 98-107.
14. Nilsson J, Fredrikson GN, Bjorkbacka H, Chyu KY, Shah PK. Vaccines modulating lipoprotein autoimmunity as a possible future therapy for cardiovascular disease. J Intern Med. 2009;266(3):221-231.